Medi-first Plus Burn With Lidocaine Cream
Product Images NDC 47682-985

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Medi-first Plus Burn With Lidocaine (NDC 47682-985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unifirst First Aid Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mf Burn (Mf Burn26073 Nantong Ultrad 1 12 2023 Label)

Mf Burn (Mf Burn26073 Nantong Ultrad 1 12 2023 Label)
This is a drug fact sheet for Medifirst Burn Cream with Lidocaine. It contains warnings, usage instructions, and information on active and inactive ingredients. It is designed for external use only and is only to be used on minor burns. The formula includes antiseptics and painkillers, and it listed by item number 26073. The text also includes a phone number for the product's manufacturer, but is not available in its entirety due to errors.*
FDA Label Image

Mfp Burn (Mfp Burn93973 Nantong Ultrad 1 12 2023 (002) Label)

Mfp Burn (Mfp Burn93973 Nantong Ultrad 1 12 2023 (002) Label)
This appears to be the packaging and drug facts for a burn cream with Lidocaine, which is an over-the-counter product used for temporary relief of pain associated with minor burns and protection against harmful bacteria. The package contains 25 packets of 0.9g (1/32 oz) each, and the active ingredients are listed as Benzalkonium Chloride 0.13% (topical antiseptic) and Lidocaine HCl 0.5% (topical analgesic). The cream should be applied externally up to 4 times daily, but not to open wounds, eyes, or large areas of skin. If ingested, medical help or contact with a Poison Control Center should be sought immediately. If symptoms worsen, persist for more than 7 days, or reoccur within a few days of use, the user should stop and contact a doctor. Other details about the cream's packaging, non-medicinal ingredients, and manufacturer contact information are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.